Location permission needed for a better experience.
How can we help you?
CV
Memberships
Publications
Education
  • 2011 Tıpta Uzmanlık Kurulu Çocuk Romatolojisi
  • 1999 - 2000 NIH, Washington DC, Amerika Bileşik Devletlerinde Bartter Sendromu konusunda çalışmıştır.
  • 1999 Hacettepe Üniversitesi Tıp Fakültesi / Pediatri Profesörü
  • 1994 - 1995 TUBİTAK NATO bursunu alarak Londra Guys ve Hammersmith Hastaneleri, Londra İngilterede, kronik böbrek yetmezliği, transplantasyon ve sistemik lupus eritematozis konularında çalışmıştır.
  • 1991 Hacettepe Üniversitesi Tıp Fakültesi Çocuk Nefrolojisi
  • 1991 Hacettepe Üniversitesi Tıp Fakültesi / Pediatri Doçenti
  • 1988 Hacettepe Üniversitesi Tıp Fakültesi / Çocuk Sağlığı Anabilim Dalı / Öğretim Görevlisi
  • 1984 - 1985 Foothills Hospital, Calgary, Kanada''da çalışmıştır.
  • 1984 Hacettepe Üniversitesi Tıp Fakültesi Çocuk Sağlığı ve Hastalıkları
  • 1980 Hacettepe Üniversitesi Tıp Fakültesi
Experience
  • 2023 Acıbadem Sağlık Grubu
  • 1988 - 2023 Hacettepe Tıp Fakültesi Öğretim Üyesi Çocuk Nefrolojisi ve Romatolojisi Bilim Dalları
  • 2019 - 2022 ESPN (Avrupa Pediatik Nefroloji Kurumu) başkanlığına seçilmiştir
  • 2014 IPNA (Internasyonel Pediarik Nefroloji Kurumu) dünya genç Nefrologlar eğitim komitesi başkanı / Halen
  • 2003 - 2012 Hacettepe Üniversitesi Tıp Fakültesi Profesör Temsilciliği, Fakülte Kurulu ve Fakülte Yönetim Kurulu Üyeliği , Uluslararası Socrates Erasmus Tıp Fakültesi Koordinatörlüğü
  • 1986 - 1988 Samsun Devlet Hastanesi / Çocuk Sağlığı ve Hastalıkları / Zorunlu Hizmet
  • 1980 - 1984 Hacettepe Tıp Fakültesi Çocuk Hastalıkları ana bilim dalı uzmanlık
  • Uluslararası dergilerde yayınlanmış 341 yayını ve çalışması vardır. Bu çalışmalar 7751 kez refere edilmiştir. H indeksi 41
Memberships
  • Internasyonel Pediarik Nefroloji Kurumu (IPNA)
  • Avrupa Pediatik Nefroloji Kurumu (ESPN)
  • Avrupa Nefroloji Kurumu (ERA)
  • Çocuk Romotoloji Derneği
  • Çocuk Nefroloji Derneği (ÇND)
  • Türk Nefroloji Derneği (TND)
Publications
  • Emulation of the control cohort of a randomized controlled trial in pediatric kidney transplantation with Real-World Data from the CERTAIN Registry. Pediatr Nephrol. 2023 May;38(5):1621-1632. doi: 10.1007/s00467-022-05777-x. Epub 2022 Oct 20. PMID: 36264431 Patry C, Sauer LD, Sander A, Krupka K, Fichtner A, Brezinski J, Geissbühler Y, Aubrun E, Grinienko A, Strologo LD, Haffner D, Oh J, Grenda R, Pape L,
  • Omic Studies on In Vitro Cystinosis Model: siRNA-Mediated CTNS Gene Silencing in HK-2 Cells. Lab Invest. 2023 Nov 9;104(1):100287. doi: 10.1016/j.labinv.2023.100287. Online ahead of print. PMID: 37949358 Baysal İ, Yabanoglu-Ciftci S, Nemutlu E, Eylem CC, Gök-Topak ED, Ulubayram K, Kır S, Gulhan B, Uçar G, Ozaltin F, Topaloglu R.
  • Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium. Kidney Int Rep. 2023 Aug 4;8(10):2029-2042. doi: 10.1016/j.ekir.2023.07.025. eCollection 2023 Oct. PMID: 37849991 Metry EL, Garrelfs SF, Deesker LJ, Acquaviva C, D''Ambrosio V, Bacchetta J, Beck BB, Cochat P, Collard L, Hogan J, Ferraro PM, Franssen CFM, Harambat J
  • Long-term renal survival of paediatric patients with lupus nephritis. Nephrol Dial Transplant. 2022 May 25;37(6):1069-1077. doi: 10.1093/ndt/gfab152. PMID: 33826705 Demir S, Gülhan B, Özen S, Çeleğen K, Batu ED, Taş N, Orhan D, Bilginer Y, Düzova A, Ozaltin F, Topaloğlu R.
  • Distal renal tubular acidosis: ERKNet/ESPN clinical practice points. Nephrol Dial Transplant. 2021 Aug 27;36(9):1585-1596. doi: 10.1093/ndt/gfab171. PMID: 33914889 Trepiccione F, Walsh SB, Ariceta G, Boyer O, Emma F, Camilla R, Ferraro PM, Haffner D, Konrad M, Levtchenko E, Lopez-Garcia SC, Santos F, Stabouli S,
  • Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth. Front Pediatr. 2019 Jul 30;7:313. doi: 10.3389/fped.2019.00313. eCollection 2019. PMID: 31417883 Topaloglu R, Gülhan B, Çelegen K, İnözü M, Hayran M, Düzova A, Ozaltin F.
  • The Clinical and Mutational Spectrum of Turkish Patients with Cystinosis. Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1634-1641. doi: 10.2215/CJN.00180117. Epub 2017 Aug 9. PMID: 28793998 Topaloglu R, Gulhan B, İnözü M, Canpolat N, Yilmaz A, Noyan A, Dursun İ, Gökçe İ, Gürgöze MK, Akinci N, Baskin E, Serdaroğlu E, Demircioğlu Kiliç B,
  • Genetic basis of cystinosis in Turkish patients: a single-center experience. Pediatr Nephrol. 2012 Jan;27(1):115-21. doi: 10.1007/s00467-011-1942-6. Epub 2011 Jul 24. PMID: 21786142 Topaloglu R, Vilboux T, Coskun T, Ozaltin F, Tinloy B, Gunay-Aygun M, Bakkaloglu A, Besbas N, van den Heuvel L, Kleta R, Gahl WA
  • A candidate gene for familial Mediterranean fever. Nat Genet. 1997 Sep;17(1):25-31. doi: 10.1038/ng0997-25. PMID: 9288094 A Bernot, C Clepet, C Dasilva, C Devaud, J L Petit, C Caloustian, C Cruaud, D Samson, F Pulcini, J Weissenbach, R Heilig, C Notanicola, C Domingo, M R
  • Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family. Kidney Int. 1996 Aug;50(2):635-42. doi: 10.1038/ki.1996.359. Topaloglu R, Bakkaloglu A, Slingsby JH, Mihatsch MJ, Pascual M, Norsworthy P, Morley BJ, Saatci U, Schifferli JA, Walport MJ.

Contact Us

Fill out the form below for your information requests

As Acıbadem Healthcare Group, you can report your requests, suggestions, thanks and complaints by filling out the form below or by contacting us at +90 444 55 44 so that we can provide you with a better and higher quality service.

See More
See More
Security Code

INFORMATION FORM WITH REGARD TO OBTAINING AND PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. (“Acıbadem”) and Acıbadem’s controlling shareholders, parent companies and affiliates (hereinafter to be collectively referred to as “Acıbadem Group”) may, acting as “Data Supervisor” under the Law on Protection of Personal Data no. 6698 (the “Law”) and other pertinent laws and regulations, process your personal data within the following frame and in strict compliance with the Basic Healthcare Services Law no. 3359, the Governmental Decree-Law on Organization and Duties of the Ministry of Health and its Affiliated Companies no. 663, the Private Hospitals Regulation, and other regulations of the Ministry of Health, and other applicable laws and provisions.

1. Obtaining and Processing of Personal Data, and Purposes of Processing:

Your personal data is collected and obtained verbally, in writing, or in visual or electronic media, through call center, internet site, verbally, in writing or similar other channels for conduct of such services as protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services offered by Acıbadem Group, or for planning and management of healthcare services and financing, and in accordance with the fields of business of Acıbadem Group Companies. Your general personal data and special personal data, especially your healthcare data, may be processed by the Group to a limited extent for all and any purposes, including, but not limited to, the following purposes:

All kinds of your personal data obtained by Acıbadem Group (including, but not limited to, your special personal data) may be processed for the following purposes:

Your personal data obtained and processed pursuant to the applicable laws and regulations may be transferred to physical archives and/or information systems of Acıbadem or Acıbadem Group and may be kept and stored both in digital and in physical platforms.

2. Transfer of Personal Data

Your personal data may be shared by Acıbadem and Acıbadem Group with companies included in Acıbadem Group or with private insurance companies, Ministry of Health and its sub-units, Social Security Agency, Security General Directorate and other security forces, General Directorate of Population and Census, Turkish Pharmacists’ Association, courts and all kinds of other juridical authorities, central etc. third parties, your authorized representatives and agents, and third parties offering consulting and advice services to us, including, but not limited to, lawyers, tax and financial consultants and auditors, and our business partners and other third parties acting in cooperation with us for further development or performance of healthcare services for the purposes cited above, also including regulatory and supervisory bodies and authorities, and official authorities, for the purposes of processing listed above, in accordance with the Law and other applicable laws and regulations.

3. Methods and Legal Causes of Obtaining of Personal Data

Your personal data are collected and processed in all kinds of verbal, written, visual or electronic media, for the purposes listed hereinabove, and for performance of all kinds of works included in the fields of business of Acıbadem within the legal framework, and accordingly, for full and proper performance of all kinds of contractual and legal duties and obligations of Acıbadem. Legal causes of collection and acquisition of your personal data are the pertinent provisions of:

Furthermore, as stipulated in 3rd paragraph of article 6 of the Law, personal data relating to health may also be processed by persons under secrecy obligations or by authorized official entities and organizations, without being liable to receive prior explicit consent of the relevant purpose, only for protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services, and for planning and management of healthcare services and financing.

4. Your Rights Regarding Protection of Personal Data

Pursuant to the Law and other relevant applicable laws and regulations, you are entitled:

If at any time you use any one or more of your aforesaid rights, the relevant information will be transmitted to you clearly and in an understandable manner, in writing or in electronic media, by using the communication data and information provided by you.

5. Data Security

Acıbadem protects your personal data in full and strict compliance with all technical and administrative security controls required to be taken in accordance with information security standards and procedures. Said security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

6. Complaints and Communications

Your personal data are protected within the frame of the available technical and administrative possibilities, and the required security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

By filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the , “https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html” web address, you may transmit and submit your legal requests:

You are hereby kindly requested to transmit your legal requests under the Law by filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html web address and sending it to us by the communication means set forth in the form.

TOP